US pharmacy pricing
Kyprolis Prices at US Pharmacies
Lowest price found · US pharmacies
$1,852.77/fill
for Kyprolis, across the pharmacies in our data
US pharmacy prices — 30mg
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
| $1,852.77Lowest | $1,855.77 | $1,473.83 | |
| $1,852.77Lowest | $1,855.77 | $1,473.83 | |
| $1,945.35 | $1,948.35 | $1,473.83 | |
| $1,957.96 | $1,960.96 | $1,473.83 | |
| $2,000.37 | $2,003.37 | $1,473.83 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Interchangeable forms
Per RxNorm (U.S. National Library of Medicine), these share the same active ingredient and strength as Kyprolis.
Frequently asked questions
What's the cash price for Kyprolis (Kyprolis) in the US?
At the US pharmacies in our data, the lowest listed discount-card price for Kyprolis is around $1,852.77. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.
Is a generic version of Kyprolis available?
Generic and brand-name pricing for Kyprolis is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
What will Kyprolis cost with my health insurance plan?
The out-of-pocket cost for Kyprolis with insurance varies significantly by plan, including factors like your deductible, copay, or coinsurance. You should contact your insurance provider directly to confirm coverage details and your estimated cost. If your plan does not cover Kyprolis, or if your copay is high, you can inquire about alternative savings options such as manufacturer patient assistance programs or pharmacy discount cards. It can be helpful to compare the final price using different payment methods at your pharmacy.
Is there a generic alternative to Kyprolis?
Kyprolis is the brand name for carfilzomib, manufactured by Amgen. As of now, a generic (bioequivalent) version of carfilzomib is not available in the United States.